• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

完整的激肽释放酶激活组图谱:激肽释放酶9、10和15激活图谱的研究

A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15.

作者信息

Yoon Hyesook, Blaber Sachiko I, Debela Mekdes, Goettig Peter, Scarisbrick Isobel A, Blaber Michael

机构信息

Department of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306-4300, USA.

出版信息

Biol Chem. 2009 Apr;390(4):373-7. doi: 10.1515/BC.2009.026.

DOI:10.1515/BC.2009.026
PMID:19090718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2838389/
Abstract

We previously reported the activation profiles of the human kallikrein-related peptidases (KLKs) as determined from a KLK pro-peptide fusion-protein system. That report described the activity profiles of 12 of the 15 mature KLKs versus the 15 different pro-KLK sequences. The missing profiles in the prior report, involving KLK9, 10, and 15, are now described. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis, mass spectrometry, and N-terminal sequence analyses show that KLK9 and 10 exhibit low hydrolytic activities towards all of the 15 pro-KLK sequences, while KLK15 exhibits significant activity towards both Arg- and Lys-containing KLK pro-sequences. The ability of KLK15 to activate pro-KLK8, 12, and 14 is confirmed using recombinant pro-KLK proteins, and shown to be significant for activation of pro-KLK8 and 14, but not 12. These additional data for KLK9, 10, and 15 now permit a completed KLK activome profile, using a KLK pro-peptide fusion-protein system, to be described. The results suggest that KLK15, once activated, can potentially feed back into additional pro-KLK activation pathways. Conversely, KLK9 and 10, once activated, are unlikely to participate in further pro-KLK activation pathways, although similar to KLK1 they may activate other bioactive peptides.

摘要

我们之前报道了通过激肽释放酶原相关肽酶(KLK)前肽融合蛋白系统测定的人KLK的激活谱。该报告描述了15种成熟KLK中的12种相对于15种不同的前激肽释放酶原序列的活性谱。现在描述了先前报告中缺失的涉及KLK9、10和15的谱。十二烷基硫酸钠-聚丙烯酰胺凝胶电泳、质谱分析和N端序列分析表明,KLK9和10对所有15种前激肽释放酶原序列均表现出低水解活性,而KLK15对含精氨酸和赖氨酸的激肽释放酶原前序列均表现出显著活性。使用重组前激肽释放酶原蛋白证实了KLK15激活前激肽释放酶原8、12和14的能力,并且表明该能力对激活前激肽释放酶原8和14具有重要意义,但对激活前激肽释放酶原12没有意义。现在,利用KLK前肽融合蛋白系统,这些关于KLK9、10和15的额外数据使得完整的KLK激活组谱得以描述。结果表明,KLK15一旦被激活,可能会反馈到其他前激肽释放酶原激活途径中。相反,KLK9和10一旦被激活,不太可能参与进一步的前激肽释放酶原激活途径,尽管它们与KLK1类似,可能会激活其他生物活性肽。

相似文献

1
A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15.完整的激肽释放酶激活组图谱:激肽释放酶9、10和15激活图谱的研究
Biol Chem. 2009 Apr;390(4):373-7. doi: 10.1515/BC.2009.026.
2
Activation profiles and regulatory cascades of the human kallikrein-related peptidases.人激肽释放酶相关肽酶的激活谱和调控级联反应。
J Biol Chem. 2007 Nov 2;282(44):31852-64. doi: 10.1074/jbc.M705190200. Epub 2007 Sep 6.
3
Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.血栓形成轴蛋白酶对人激肽释放酶相关肽酶的激活谱
Protein Sci. 2008 Nov;17(11):1998-2007. doi: 10.1110/ps.036715.108. Epub 2008 Aug 12.
4
Gene Expression of Kallikreins in Breast Cancer Cell Lines.乳腺癌细胞系中 Kallikreins 的基因表达。
Anticancer Res. 2020 May;40(5):2487-2495. doi: 10.21873/anticanres.14219.
5
Kallikrein-related peptidases protein expression in lymphoid tissues suggests potential implications in immune response.组织中的激肽释放酶相关肽酶蛋白表达提示其在免疫反应中具有潜在的影响。
Clin Biochem. 2020 Mar;77:41-47. doi: 10.1016/j.clinbiochem.2019.12.015. Epub 2020 Jan 2.
6
A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate Cancer.一套基于活性的探针,用于剖析耐药性前列腺癌中的 KLK 激活组。
J Am Chem Soc. 2021 Jun 16;143(23):8911-8924. doi: 10.1021/jacs.1c03950. Epub 2021 Jun 4.
7
Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.激肽释放酶相关肽酶(KLKs)作为新兴治疗靶点:聚焦于前列腺癌和皮肤疾病
Expert Opin Ther Targets. 2016 Jul;20(7):801-18. doi: 10.1517/14728222.2016.1147560. Epub 2016 Mar 4.
8
Functional roles of human kallikrein-related peptidases.人激肽释放酶相关肽酶的功能作用。
J Biol Chem. 2009 Nov 27;284(48):32989-94. doi: 10.1074/jbc.R109.027946. Epub 2009 Oct 9.
9
Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases.基质金属蛋白酶对人激肽释放酶相关肽酶的激活作用。
Biol Chem. 2013 Jan;394(1):137-47. doi: 10.1515/hsz-2012-0249.
10
The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.GNA13-RhoA信号轴抑制肿瘤保护性激肽释放酶的表达。
Cell Signal. 2016 Oct;28(10):1479-88. doi: 10.1016/j.cellsig.2016.07.001. Epub 2016 Jul 14.

引用本文的文献

1
A KLK6 Activity-Based Probe Reveals a Role for KLK6 Activity in Pancreatic Cancer Cell Invasion.一种 KLK6 活性探针揭示了 KLK6 活性在胰腺癌细胞侵袭中的作用。
J Am Chem Soc. 2022 Dec 14;144(49):22493-22504. doi: 10.1021/jacs.2c07378. Epub 2022 Nov 22.
2
A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate Cancer.一套基于活性的探针,用于剖析耐药性前列腺癌中的 KLK 激活组。
J Am Chem Soc. 2021 Jun 16;143(23):8911-8924. doi: 10.1021/jacs.1c03950. Epub 2021 Jun 4.
3
Surface loops of trypsin-like serine proteases as determinants of function.

本文引用的文献

1
Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.血栓形成轴蛋白酶对人激肽释放酶相关肽酶的激活谱
Protein Sci. 2008 Nov;17(11):1998-2007. doi: 10.1110/ps.036715.108. Epub 2008 Aug 12.
2
Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration.激肽释放酶与继发进展型多发性硬化症相关,并促进神经退行性变。
Biol Chem. 2008 Jun;389(6):739-45. doi: 10.1515/BC.2008.085.
3
Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression.
表面环的胰蛋白酶样丝氨酸蛋白酶作为功能的决定因素。
Biochimie. 2019 Nov;166:52-76. doi: 10.1016/j.biochi.2019.09.004. Epub 2019 Sep 7.
4
Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.高级别浆液性卵巢癌患者肿瘤组织中激肽释放酶相关肽酶 4(KLK4)mRNA 表达的特征。
PLoS One. 2019 Feb 27;14(2):e0212968. doi: 10.1371/journal.pone.0212968. eCollection 2019.
5
Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.高级别浆液性卵巢癌:肿瘤组织和患者预后中 KLK13 和 KLK14 mRNA 水平的反比关系。
J Cancer Res Clin Oncol. 2018 Jun;144(6):1109-1118. doi: 10.1007/s00432-018-2623-7. Epub 2018 Mar 15.
6
Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.激肽释放酶-激肽系统在神经紊乱中的意义:探寻潜在的生物标志物和机制。
Prog Neurobiol. 2018 Jun-Aug;165-167:26-50. doi: 10.1016/j.pneurobio.2018.01.003. Epub 2018 Jan 31.
7
An unexpected switch in peptide binding mode: from simulation to substrate specificity.一种意想不到的肽结合模式转变:从模拟到底物特异性。
J Biomol Struct Dyn. 2018 Nov;36(15):4072-4084. doi: 10.1080/07391102.2017.1407674. Epub 2018 Jan 31.
8
Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10.锌离子对类酶原激肽释放酶相关肽酶10抑制作用的结构基础
Biol Chem. 2016 Dec 1;397(12):1251-1264. doi: 10.1515/hsz-2016-0205.
9
Putative functions of tissue kallikrein-related peptidases in vaginal fluid.推测组织激肽释放酶相关肽酶在阴道液中的作用。
Nat Rev Urol. 2016 Oct;13(10):596-607. doi: 10.1038/nrurol.2016.161. Epub 2016 Sep 7.
10
A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity.人组织激肽释放酶相关肽酶2 99环处的单个聚糖调节激活和酶活性。
J Biol Chem. 2016 Jan 8;291(2):593-604. doi: 10.1074/jbc.M115.691097. Epub 2015 Nov 18.
激肽释放酶相关肽酶4(KLK4)通过蛋白酶激活受体(PARs)启动细胞内信号传导。在前列腺癌进展过程中,KLK4和PAR-2共同表达。
J Biol Chem. 2008 May 2;283(18):12293-304. doi: 10.1074/jbc.M709493200. Epub 2008 Feb 28.
4
Expression of kallikrein-related peptidases (KRP/hK5, 7, 6, 8) in subtypes of human lung carcinoma.激肽释放酶相关肽酶(KRP/hK5、7、6、8)在人肺癌亚型中的表达
Int Immunopharmacol. 2008 Feb;8(2):300-6. doi: 10.1016/j.intimp.2007.08.015. Epub 2007 Sep 6.
5
Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin.人激肽释放酶相关肽酶14(KLK14)是激肽释放酶蛋白水解级联反应的一种新的激活成分。在精浆和皮肤中可能具有的功能。
J Biol Chem. 2008 Feb 8;283(6):3031-3041. doi: 10.1074/jbc.M707253200. Epub 2007 Dec 3.
6
Activation profiles and regulatory cascades of the human kallikrein-related peptidases.人激肽释放酶相关肽酶的激活谱和调控级联反应。
J Biol Chem. 2007 Nov 2;282(44):31852-64. doi: 10.1074/jbc.M705190200. Epub 2007 Sep 6.
7
Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.正常生理和癌症中的组织激肽释放酶蛋白水解级联途径。
Biochim Biophys Acta. 2007 Sep;1776(1):22-31. doi: 10.1016/j.bbcan.2007.06.001. Epub 2007 Jun 14.
8
The autolytic regulation of human kallikrein-related peptidase 6.人组织激肽释放酶相关肽酶6的自溶调节
Biochemistry. 2007 May 1;46(17):5209-17. doi: 10.1021/bi6025006. Epub 2007 Apr 7.
9
Potential scope of action of tissue kallikreins in CNS immune-mediated disease.
J Neuroimmunol. 2006 Sep;178(1-2):167-76. doi: 10.1016/j.jneuroim.2006.05.022. Epub 2006 Jul 7.
10
A comprehensive nomenclature for serine proteases with homology to tissue kallikreins.与组织激肽释放酶具有同源性的丝氨酸蛋白酶的综合命名法。
Biol Chem. 2006 Jun;387(6):637-41. doi: 10.1515/BC.2006.082.